In addition to the anti-inflammatory effect of anti-TNF-α therapy, and the consequential improvement in joint function, they may indirectly lead to increased levels of physical activity, which will subsequently decrease the incidence of other CV risk factors, such as diabetes mellitus and hypertension [114]. This evidence concerns the gene TNF and hypertensive disorder.